GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Change In Receivables

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Change In Receivables : د.إ-74 Mil (TTM As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Change In Receivables?

Gulf Pharmaceutical Industries PSC's change in receivables for the quarter that ended in Mar. 2025 was د.إ-81 Mil. It means Gulf Pharmaceutical Industries PSC's Accounts Receivable increased by د.إ81 Mil from Dec. 2024 to Mar. 2025 .

Gulf Pharmaceutical Industries PSC's change in receivables for the fiscal year that ended in Dec. 2024 was د.إ-30 Mil. It means Gulf Pharmaceutical Industries PSC's Accounts Receivable increased by د.إ30 Mil from Dec. 2023 to Dec. 2024 .

Gulf Pharmaceutical Industries PSC's Accounts Receivable for the quarter that ended in Mar. 2025 was د.إ616 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Gulf Pharmaceutical Industries PSC's Days Sales Outstanding for the three months ended in Mar. 2025 was 156.44.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Gulf Pharmaceutical Industries PSC's liquidation value for the three months ended in Mar. 2025 was د.إ66 Mil.


Gulf Pharmaceutical Industries PSC Change In Receivables Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Change In Receivables Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.60 349.80 -68.90 10.60 -29.70

Gulf Pharmaceutical Industries PSC Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.50 -64.10 15.90 55.00 -80.80

Gulf Pharmaceutical Industries PSC Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ-74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Gulf Pharmaceutical Industries PSC's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=615.8/359.2*91
=156.44

2. In Ben Graham's calculation of liquidation value, Gulf Pharmaceutical Industries PSC's accounts receivable are only considered to be worth 75% of book value:

Gulf Pharmaceutical Industries PSC's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=483.9-1082.7+0.75 * 615.8+0.5 * 405.9
=66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC Change In Receivables Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Gulf Pharmaceutical Industries PSC Business Description

Traded in Other Exchanges
N/A
Address
Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Planet, Investments, and others. The majority of its revenue is generated from the planet segment. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC Headlines

No Headlines